Stanton Chase uses cookies to ensure you get the best experience on our website. Learn More I accept

International Chairman Weighs In on M&A at Pfizer

by Mickey Matthews July 2019
Share LinkedIn Share E-mail
International Chairman Weighs In on M&A at Pfizer Cover Image

Mickey Matthews Discusses Departure of Mylan CFO

Mergers and acquisitions often result in significant changes in the C-suite, and the recent transition at Pfizer is no exception. In the following article, Mickey Matthews, Stanton Chase International Chairman and Managing Director of the Baltimore office, explains why the departure of Mylan’s CFO is not unusual and what the employment outlook is for executive leaders in similar circumstances.

Read the full article here: https://www.wsj.com/articles/mylan-cfo-set-to-leave-as-part-of-pfizer-deal-11564436873

Featured Articles

Why Are U.S. Companies Hiring More External Candidates?

Read

It’s Time to Rethink Diversity and Inclusion Recruitment

Read

Fostering Positive Leadership

Read

Contact a Stanton Chase office near you

Find an office